<DOC>
	<DOCNO>NCT02054871</DOCNO>
	<brief_summary>This study aim demonstrate remote ischaemic preconditioning ( RIPC ) may confer renal protection patient undergoing peripheral angioplasty . Patients randomise receive RIPC biomarkers renal injury analyse post procedure determine protective benefit obtain .</brief_summary>
	<brief_title>RCT Evaluate Renal Protective Effects Remote Ischaemic Preconditioning Peripheral Angioplasty</brief_title>
	<detailed_description>Ischaemic precondition endogenous mammalian mechanism whereby brief period ischaemia reperfusion confers resistance subsequent prolonged ischaemic insult . First observe canine heart , subsequent investigator note brief ischaemia remote organ e.g . skeletal muscle , induced protection key central organ e.g . heart . This remote ischaemic preconditioning ( RIPC ) require direct interference target organ ' blood supply . It induce use blood pressure cuff produce brief episode upper limb ischaemia reperfusion confers protection upon numerous organ simultaneously . RIPC reduce myocardial injury follow aortic aneurysm repair , cardiac surgery angioplasty . It also reduce adverse ischaemic event six month follow percutaneous coronary intervention , imply medium-term effect . To date ischaemic conditioning apply primarily heart however animal study show pre conditioning offer renal protection . Fikret et al 2012 Renal Protection Trial demonstrate protective benefit RIPC development CIN high risk patient undergo elective coronary angiography.Whittaker Przyklenk 2011 explore concept retrospectively use data patient undergone emergency angioplasty ST elevation myocardial infarction . The original trial RCT examine protective effect postconditioning myocardial ischemia . The author retrospectively examine study patient treat multiple coronary balloon inflation well renal function patient expose remote conditioning . They conclude patient condition group receive 25 % contrast volume control group show decline renal function demonstrate examination glomular filtration rate day 3 post procedure comparison control group saw significant decline renal function . The need contrast-based procedure rise , increase number patient undergo endovascular procedure , incidence postcontrast renal failure , report mortality 34 % . The potential use RIPC therefore reduce risk kidney damage need investigation prospective study PAD patient group routinely expose contrast administration angiography ideal study group .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Elective intraarterial , infrainguinal peripheral angiography/angioplasty Written inform consent Patients &gt; 18yrs age Patients CKD ( Stage2/3 ) evidence eGFR &lt; 90ml/min/1.73m2 Severe renal impairment eGFR &lt; 30ml/min Evidence acute renal failure patient dialysis History previous CIN Contraindication intravenous volume replacement therapy Pregnancy Patients glibenclamide nicorandil ( medication may interfere RIPC )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Peripheral Angioplasty</keyword>
	<keyword>Remote Ischaemic Preconditioning</keyword>
	<keyword>Contrast Induced Nephropathy</keyword>
</DOC>